The finding that the JAK/STAT signaling pathway is activated in diabetic kidney disease (DKD) progression based on the analysis of omics data for example has led to the investigation of the JAK inhibitor baricitinib. The gene discussed is SOAT1; the disease is diabetic kidney disease.